Milataxel
Alternative Names: MAC-321; MAC-321 IV; TL 00139; TL-139Latest Information Update: 10 Feb 2010
At a glance
- Originator Taxolog
- Class Antineoplastics; Benzoic acids; Taxanes
- Mechanism of Action Tubulin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Breast cancer; Colorectal cancer; Malignant-mesothelioma; Non-small cell lung cancer
Most Recent Events
- 01 May 2006 Data presented at the 97th Annual Meeting of the American Association for Cancer Research (AACR-2006) have been added to the pharmacokinetics section
- 13 Oct 2005 Wyeth has reverted the licence for milataxel to Taxolog
- 02 Sep 2004 A clinical study has been added to the adverse events section